Drug Database
Back to search

Switzerland· 00603001

Hiberix, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung

A haemophilus influenzae b, gereinigtes antigen konjugiert product containing polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetani, registered in Switzerland by GlaxoSmithKline AG and dispensed under Swissmedic category B. The same ATC class is registered in 8 of our 19 countries.

Cat B (Swissmedic)ATC J07AG01

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedHiberix, Pulver und Lösungsmittel zur…ATCJ07AG01REGISTER NO.00603001PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about polysaccharida haemophili influenzae typus b 20752 conjugata cum toxoido tetaniAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Haemophilus influenzae b, gereinigtes antigen konjugiert is registered in 8 of 19 countries.

Countries holding a registration under ATC J07AG01 (haemophilus influenzae b, gereinigtes antigen konjugiert), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 6 of them publish a price we can compare per daily dose
Search haemophilus influenzae b, gereinigtes antigen konjugiert products by name

Haemophilus influenzae b, gereinigtes antigen konjugiert · ATC J07AG01

8 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Swissmedic (Switzerland)
Active substance
polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani
Manufacturer
GlaxoSmithKline AG
Country
Switzerland (CH)
ATC code
J07AG01
ATC class
Haemophilus influenzae B, gereinigtes Antigen konjugiert
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07AG01

Haemophilus influenzae b, gereinigtes antigen konjugiert, as other registers publish it.

All haemophilus influenzae b, gereinigtes antigen konjugiert products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c4137a53-1ada-4adc-bcb2-b420e356b961
GET /v1/drugs/c4137a53-1ada-4adc-bcb2-b420e356b961?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "swissmedic_auth",
  "heilmittelcode": "Impfstoffe"
}
API referenceMCP serverPlans

See everything about haemophilus influenzae b, gereinigtes antigen konjugiert.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console